EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anemia in children and adolescents with inflammatory bowel disease at the time of diagnosis and after 1 year of treatment

Žan Ferant, Maja Pogačar, Jernej Dolinšek, Dušanka Mičetić-Turk

Acta Medico-Biotechnica · 2021

DOI: 10.18690/actabiomed.115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Medico-Biotechnica, 2021. Verfasst von Žan Ferant und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Purpose: Anemia is the most common systemic complication of inflammatory bowel disease (IBD). Depending on the diagnostic criteria and patient sub-population, the prevalence of anemia can be as high as 73.7%. Data suggest that the prevalence of anemia is often higher in the pediatric population than adults. The presence of anemia can have a significant impact on the quality of life (QOL) in patients with IBD, which can be as poor as exists in patients with advanced cancer; however, the QOL improves with restoration of the hemoglobin concentration. Because the anemia in patients with IBD is often unrecognized and/or undertreated, this potentially reversible condition is an area of great concern.

Methods

We retrospectively collected data for 44 pediatric patients (age range, 10–18 years; mean age, 14.3 years; 25 boys and 19 girls) at the time of diagnosis and after 1 year of IBD treatment and compared the IBD patients to 36 healthy children and adolescents (age range, 10–18 years; mean age, 13.7 years; 17 boys and 19 girls). We recorded the prevalence of anemia based on the World Health Organization criteria, the hemoglobin concentration, mean corpuscular volume, and iron and ferritin levels. We also compared IBD patients who were treated for anemia to untreated IBD patients.

Results

Anemia existed in 63% and 18% of IBD patients at the time of diagnosis and 1 year after treatment, respectively, and in 3% of the patients in the control group. Blood parameters in IBD patients improved after 1 year of treatment and approached the values in the control group. Of the IBD patients, 20% were treated for anemia. No statistical significance existed between IBD patients who were and were not treated for anemia.

Conclusion

Our findings suggest that anemia may improve in patients with IBD by treating the underlyingdisease; however, we also found a small percentage of patients who were treated for anemia, which is an issue that must be kept in mind.

Zitieren

APA

Ferant, Ž., Pogačar, M., Dolinšek, J., & Mičetić-Turk, D. (2021). Anemia in children and adolescents with inflammatory bowel disease at the time of diagnosis and after 1 year of treatment. Acta Medico-Biotechnica. https://doi.org/10.18690/actabiomed.115

Vancouver

Ferant Ž, Pogačar M, Dolinšek J, Mičetić-Turk D. Anemia in children and adolescents with inflammatory bowel disease at the time of diagnosis and after 1 year of treatment. Acta Medico-Biotechnica. 2021. doi:10.18690/actabiomed.115

BibTeX
@article{Ferant2021,
  author = {Ferant, Žan and Pogačar, Maja and Dolinšek, Jernej and Mičetić-Turk, Dušanka},
  title = {Anemia in children and adolescents with inflammatory bowel disease at the time of diagnosis and after 1 year of treatment},
  journal = {Acta Medico-Biotechnica},
  year = {2021},
  doi = {10.18690/actabiomed.115}
}
Kostenlos starten →